News
AI-powered Villager tool reached 11,000 PyPI downloads since July 2025, enabling scalable cyberattacks and complicating ...
PARIS — Results from the REMAIN long-term follow-up study on MCO-010, an optogenetic therapy for retinitis pigmentosa, showed durable efficacy over 3 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback